SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a sharp sell-off following its Worldwide Developers Conference (WWDC), where the reveal of "Siri AI" and an integration with Google's Gemini models was met with significant investor disappointment. The community is actively debating whether the stock's high valuation is justified given perceived innovation delays, with many traders interpreting the price action as a classic "sell the news" event while others worry about the company's competitive standing against AI rivals.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending after securing a 15-year, 210 MW data center lease with a major hyperscaler, a move that adds significant contracted revenue and highlights the company's rapid expansion into AI infrastructure. The community is actively discussing the stock's massive contracted revenue backlog, the strategic importance of this latest deal, and potential for a stock re-rating as the company scales its operations.

Cartesian Growth Corp. III is a blank check company. It was created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on October 29, 2024 and is headquartered in New York, NY.

Factorial Energy Inc. - Ordinary Shares- Class A

Factorial Energy is experiencing intense market volatility and high trading volume following its recent listing on the Nasdaq as a solid-state battery developer. The community is sharply divided, with some traders debating its potential as a momentum play backed by major automotive partners, while others characterize the price swings as a speculative pump-and-dump event.

EHang Holdings Ltd. engages in the provision of aerial vehicle technology platform company. It also provides unmanned aerial vehicle (UAV) systems and solutions: air mobility (including human transportation and logistics), smart city management, and aerial media solutions. The firm operates through the following geographical segments: P.R.C., West Asia, East Asia, South America, Europe, and Other. The company was founded by Huazhi Hu and Yifang Derrick Xiong in December 2014 and is headquartered in Guangzhou, China.

EHang Holdings Ltd - ADR

EHang Holdings

EHang continues to draw attention as investors monitor its progress toward scaling commercial operations and expanding global deployment, particularly in markets like Thailand and the Middle East. While community members remain divided over the company's timeline for recurring revenue and regulatory hurdles, ongoing interest is driven by the unveiling of new long-range models like the VT35 and the promise of a growing low-altitude economy.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc is gaining strong momentum driven by the launch of its Rev8 LiDAR sensor and a strategic partnership with Argus Interception, positioning the company as a key infrastructure player in the burgeoning Physical AI and robotics sector. Investors are actively discussing the stock's transition from a pure-play hardware vendor to an integrated perception platform, with many highlighting its expanding TAM across autonomous systems, defense, and smart infrastructure as catalysts for long-term growth.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors brace for earnings results that follow a period of volatility driven by litigation concerns and broader biotech sector pressure. The community remains focused on the commercial growth of Recorlev, the upcoming Phase 3 advancement of the XP-8121 pipeline, and the potential for long-term valuation rerating as the company moves toward sustained profitability.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is trending as investors rally behind its vision of a decentralized, AI-native alternative to GitHub that empowers autonomous agents to own and manage code repositories on-chain. The community is actively discussing the project's utility-driven tokenomics, aggressive buyback and burn plans to reduce supply, and its potential for expansion through strategic industry partnerships.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF is seeing a major breakout as investors front-run the upcoming NYSE uplisting of Trulieve and anticipate potential federal reform momentum. The community is actively debating the sector's long-term upside against regulatory risks, while many are shifting their focus to the underlying stocks poised to benefit most from structural catalysts.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending following a significant $2.6 billion agreement with Nebius Group to provide fuel cell capacity for AI data centers, which investors view as further validation of the company's critical role in solving the AI infrastructure power bottleneck. The community is actively discussing the stock's parabolic growth, debating its valuation, and drawing comparisons between Bloom's commercial success and the speculative potential of smaller clean energy plays like FuelCell Energy and Hyliion.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors react to a significant price target upgrade from Cantor Fitzgerald, which raised its outlook to $34 based on the company's strengthened IP position and patent exclusivity extending to 2041. The community is actively debating the stock's potential as a buyout candidate, with many long-term shareholders expressing frustration over the share price disconnect from fundamentals while others highlight upcoming European regulatory catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
